Study of BSF 208075 Evaluating Exercise Capacity in Patients With Pulmonary Arterial Hypertension

ClinicalTrials.gov ID: NCT00046319

Public ClinicalTrials.gov record NCT00046319. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 21, 2026, 11:21 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Randomized, Double-Blind, Dose-Controlled, Dose-Ranging, Multicenter Study of BSF 208075 Evaluating Exercise Capacity in Patients With Moderate to Severe Pulmonary Arterial Hypertension

Study identification

NCT ID: NCT00046319
Recruitment status: Completed
Study type: Interventional
Phase: Phase 2
Lead sponsor: Gilead Sciences; Industry
Enrollment: 60 participants

Conditions and interventions

Conditions

Pulmonary Hypertension

Interventions

BSF 208075 Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Aug 31, 2002
Primary completion: Not listed
Completion: May 31, 2003
Last update posted: Apr 15, 2009

2002 – 2003

United States locations

U.S. sites: 15
U.S. states: 10
U.S. cities: 15

Facility	City	State	ZIP	Site status
University of Southern California	Los Angeles	California	90089	—
University of California San Diego Medical Center	San Diego	California	92037	—
University of California - San Francisco	San Francisco	California	94143	—
Stanford University	Stanford	California	94305	—
Los Angeles County Harbor-UCLA Medical Center	Torrance	California	90502	—
University of Colorado Health Sciences Center	Denver	Colorado	80262	—
Rush Presbyterian	Chicago	Illinois	60612	—
Brigham and Women's Hospital	Boston	Massachusetts	02115	—
Mayo Clinic	Rochester	Minnesota	55905	—
New York Presbyterian Hospital	New York	New York	10032	—
Case Western Reserve University	Cleveland	Ohio	44106	—
Ohio State University	Columbus	Ohio	43210	—
Vanderbilt University Medical Center	Nashville	Tennessee	37232	—
Baylor College of Medicine	Houston	Texas	77030	—
Heart Care Associates	Milwaukee	Wisconsin	53215	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00046319, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 15, 2009 · Synced Jul 21, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00046319 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →